Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One - No Study Results Posted

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One (CARE-MS I)

This study has been completed.

Study NCT00530348 Information provided by Genzyme

First Received: September 13, 2007 Last Updated: May 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2011
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)